Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety profile of ticagrelor vs lysine acetylsalicylate + clopidogrel in TAVI
2015-004144-20Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ticagrelor in aortic stenosis (AS) (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: VARC-2 early safety composite endpoint at 30 days. Started Dec 2015; status: completed.
02
Drugs
ticagrelor
03
Conditions
aortic stenosis (AS)
Beyond the preview
Go deeper on 2015-004144-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004144-20.